
















Apolipoprotein E 2.25 0.02 Zinc-alpha-2-glycoprotein 5.43 0
Apolipoprotein
B-100
2.0137 0.0001 Histidine-rich glycoprotein 4.1305 0
Apolipoprotein
A-IV
1.9953 0.0046 Beta-2-glycoprotein 1 4.529 0.0084
Complement C5 0.3532 0.0001 Gelsolin 1.24 0
Complement C1s 0.413 0.0006 Decorin 0.20 0.04
Complement C2 0.2466 0.0014 Protein S100-A9 0.2399 0.0353
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A84the need to remove synovial ﬂuid from the joint. Moreover, measures
of biomarker per particle following the magnetic capture procedure
can be used to estimate total biomarker levels within the joint, a
measure that is less susceptible to the effects of effusion. The purpose
of this study is to demonstrate the ability of magnetic capture to
measure joint-levels of c-telopeptide of type II collagen (CTXII) levels
in a rat OA model.
Methods: Using EDC cross-linking, antibodies against CTXII were
conjugated to carboxyl groups on the surface of 780 nm diameter
polystyrene particles that contained 8.5 nm diameter SPIONs, here-
after referred to as anti-CTXII particles. To assess magnetic capture in
a rat knee, 22 Sprague-Dawley rats (90 days old, male) were acquired.
First, 6 naive rats received an intra-articular injection of 180, 360, or
720 million anti-CTXII particles (n¼4 per knees per group). Next, 8
rats received an intra-articular injection of monoiodoacetate (MIA, 3
mg in 25 mL of saline) with OA allowed to develop over 30 days; the
remaining 8 rats served as age-matched naïve controls for the MIA
animals. For MIA animals and their age-matched naïve controls, 720
million anti-CTXII particles were injected into the knee joint. For all
experiments, injected anti-CTXII particles were allowed to incubate
in the joint for 2 hrs prior to collection. Then, a 1 mm diameter by 1
mm length NdFeB magnet attached to the end of a steel rod was
inserted into the joint space through a 16 gauge catheter. Particles
were collected on the magnet for 10 minutes. Then, the magnet was
removed and washed to isolate particles. Collected particles were
heated to 85C for 3 min, followed by quantiﬁcation of collected
particles and CTXII. CTXII levels in the joint were estimated by
multiplying the ratio of biomarker to particles by the total number of
particles injected. Serum was also collected for CTXII analysis. All
studies were conducted under IACUC-approved protocols. Since the
purpose of this study was to demonstrate feasibility, all magnetic
capture procedures were conducted immediately after humane
euthanasia.
Results:Magnetic capture was able to recover detectable levels of CTXII
from all rat knees. Moreover, estimates of total CTXII levels in the joint
were independent from the number of particles injected (Figure 1a);
thus, a stable estimate of CTXII can be obtained in the rat knee using
post-mortem magnetic capture.
Using magnetic capture, elevated levels of CTXII were detected in
OA-affected joints relative to both contralateral knee and naïve
controls (Figure 1b), while CTXII concentrations in the serum of these
same animals did not yield signiﬁcant differences between MIA-
injected and age-matched naïve control animals (Figure 1c). These
data demonstrate the utility of biomarker assessments in the OA-
affected knee and the ability of magnetic capture to facilitate these
analyses.
Conclusions: Using magnetic capture, signiﬁcant changes in total
CTXII levels were detected in MIA-injected joints using 8 rats per
group. This demonstrates a marked improvement over published lav-
age techniques for the MIA model, where 19-20 animals per group are
often needed to identify signiﬁcant elevations in CTXII concentration
post-lavage. Thus combined, these data demonstrate the feasibility,
stability, and utility of magnetic capture for OA biomarker analysis in
the rat knee.103
QUANTITATIVE PROTEOMICS REVEALS PUTATIVE BIOMARKERS IN
PRE-RADIOLOGICAL OSTEOARTHRITIS
J. Mateos, A. Pintor-Iglesias, P. Fernandez-Puente, S. Rela~no,
I. Rego-Perez, N. Oreiro, C. Fernandez-Lopez, C. Ruiz-Romero,
F.J. Blanco. INIBIC-CHUAC, A Coru~na, Spain
Purpose: In this studywe have identiﬁed proteins differentially abundant
in the serum of Osteoarthritis (OA) patients comparing four different
progressive pathological grades using mass spectrometry and iTRAQ
technique for relative quantiﬁcation. Ourﬁnal aim is to establish a panel of
biomarkers useful to predict thepathology inpre-radiological stages (early
Osteoarthritis biomarkers), but also for its handling and the developing of
trials of treatment in radiological stages (late Osteoarthritis biomarkers).
Methods: 15 individual samples for each condition (OA Grade 0, pre-
radiological stage Grade I, and radiological stage grades II-III and IV)
were pooled in three groups with the aim of reducing the contribution
of individual extreme values. After enrichment in the low-abundant
protein fraction, the pooled samples were subjected to in-solution
digestion, followed by iTRAQ labelling following manufacturer
instructions and Reverse Phase peptide separation in a LC system
(Agilent 1200). Fractions were again separated in a nanoLC system
(Tempo, Eksigent) automatically deposited on a MALDI plate and ana-
lyzed by MSMS in a 4800 MALDI-TOF/TOF system (ABSciex). Relative
quantitative analysis was done using ProteinPilot software (ABSciex)
and modulated proteins were analyzed with String 9.0 software.
Results:We have detected two big sets of serum proteins modulated in
the early pre-radiological OA process. Serum levels of apolipoproteins
are altered when comparing Grade I vs. Grade 0. Speciﬁcally, apolipo-
protein E and apolipoprotein B-100, that mediates the binding, inter-
nalization, and catabolism of lipoprotein particles are accumulated in
Grade I samples. Furthermore, up to six components of the comple-
ment, a group of proteins involved in immune response and inﬂam-
mation are decreased in serum in early OA grades. Among them,
complement component 5 -C5-, that have been recently identiﬁed as
key player of the OA process, is much less abundant in any OA grade in
comparison to Grade 0. Proteins previously described as putative bio-
markers by our group and others, like histidine-rich glycoprotein, gel-
solin and decorin, are also modulated in our study, but at later
radiological stages -Grade II/III and Grade IV vs. Grade I and Grade 0-.
Conclusions: Our results indicate that early pathological grades of the OA
process are linked to an imbalance in the metabolism and, speciﬁcally, in
the lipid metabolism. Altered serum levels of apo-lipoproteins could be
used, in combinationwith other “dry” biomarkers, as an indicator for early
OA process and to detect the pathology in pre-radiological stages. Fur-
thermore, the lower serum levels in the OA grades detected for the com-
plement component 5 -C5-, strongly support recent in vivo data indicating
that a decrease of this protein is linked to the development of the disease.104
STATUS OF OXIDATIVE STRESS BIOMARKERS IN OSTEOARTHRITIS
PATIENTS IN NORTH INDIAN POPULATION
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Purpose: Osteoarthritis (OA) is the most common type of arthritis in
which there is membrane / cartilage destruction leading to bone
